Latest filing published 06 Oct 2017 for Lumos Pharma, INC., €6.8M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stine Seed Farm, Inc.: trading record in brief
This profile gathers the share dealings of Stine Seed Farm, Inc. in Lumos Pharma, Inc. Between 16 November 2011 and 6 October 2017, the trades on record add up to 7 filings.
No open-market sale appears; the market trades are 3 purchases worth €25.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2017: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €7.4M.
The latest filing, published on 6 October 2017, reports an open-market purchase of €6.8M in Lumos Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stine Seed Farm, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 780,487 shares@ US$10.25100.0% of flowCommon StockSEC:0001126234-17-000099:0Canonical exit: 4 Jan 2018 (T+90)
- 880,000 shares@ US$11.40Common StockSEC:0001126234-13-000033:0Canonical exit: 5 May 2013 (T+90)
- 838,095 sharesCommon StockSEC:0001104659-11-065229:0
- 542,820 sharesCommon StockSEC:0001104659-11-065229:1
- 814,231 sharesCommon StockSEC:0001104659-11-065229:2
- 1,680,671 sharesCommon StockSEC:0001104659-11-065229:3
- 2,142,857 shares@ US$7.00Common StockSEC:0001104659-11-065229:4Canonical exit: 14 Feb 2012 (T+90)
7 of 7 declarations